{"id":"https://openalex.org/W4396998166","doi":"https://doi.org/10.1681/asn.20203110s1670b","title":"Double Trouble with Pembrolizumab: Immune Checkpoint Inhibitor-Induced Type 1 Renal Tubular Acidosis and Secondary Adrenal Insufficiency","display_name":"Double Trouble with Pembrolizumab: Immune Checkpoint Inhibitor-Induced Type 1 Renal Tubular Acidosis and Secondary Adrenal Insufficiency","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W4396998166","doi":"https://doi.org/10.1681/asn.20203110s1670b"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20203110s1670b","doi":"https://doi.org/10.1681/asn.20203110s1670b","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1681/asn.20203110s1670b","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018067460","display_name":"Dayyan M. Adoor","orcid":"https://orcid.org/0000-0001-9346-4100","observed_orcids":["https://orcid.org/0000-0001-9346-4100"]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dayyan M. Adoor","raw_affiliation_strings":["University Hospitals, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals, Cleveland, OH","institution_ids":["https://openalex.org/I2799343972"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074895061","display_name":"Hafsa Tariq","orcid":"https://orcid.org/0009-0006-4847-5576","observed_orcids":["https://orcid.org/0009-0006-4847-5576"]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hafsa Tariq","raw_affiliation_strings":["University Hospitals, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals, Cleveland, OH","institution_ids":["https://openalex.org/I2799343972"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070098394","display_name":"Arash Rashidi","orcid":"https://orcid.org/0000-0002-5982-1925","observed_orcids":["https://orcid.org/0000-0002-5982-1925"]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arash Rashidi","raw_affiliation_strings":["University Hospitals, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals, Cleveland, OH","institution_ids":["https://openalex.org/I2799343972"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2799343972"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"10S","first_page":"670","last_page":"670"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.875},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.6899999976158142},{"id":"https://openalex.org/keywords/distal-renal-tubular-acidosis","display_name":"distal renal tubular acidosis","score":0.9300000071525574},{"id":"https://openalex.org/keywords/secondary-adrenal-insufficiency","display_name":"secondary adrenal insufficiency","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hyponatremia","display_name":"hyponatremia","score":0.7749999761581421},{"id":"https://openalex.org/keywords/metabolic-acidosis","display_name":"metabolic acidosis","score":0.8360000252723694},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.6970000267028809},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6620000004768372},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.8410000205039978},{"id":"https://openalex.org/keywords/hypokalemia","display_name":"hypokalemia","score":0.6230000257492065},{"id":"https://openalex.org/keywords/urine-anion-gap","display_name":"urine anion gap","score":0.6190000176429749},{"id":"https://openalex.org/keywords/osmolal-gap","display_name":"osmolar gap","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.927266538143158},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7311011552810669},{"id":"https://openalex.org/C2778129406","wikidata":"https://www.wikidata.org/wiki/Q2507454","display_name":"Adrenal insufficiency","level":2,"score":0.6862809658050537},{"id":"https://openalex.org/C2776598079","wikidata":"https://www.wikidata.org/wiki/Q2896802","display_name":"Distal renal tubular acidosis","level":3,"score":0.6186782717704773},{"id":"https://openalex.org/C2778553927","wikidata":"https://www.wikidata.org/wiki/Q185089","display_name":"Acidosis","level":2,"score":0.5249245762825012},{"id":"https://openalex.org/C2781079508","wikidata":"https://www.wikidata.org/wiki/Q1516211","display_name":"Renal tubular acidosis","level":3,"score":0.5231515169143677},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45556214451789856},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.32714223861694336},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25445884466171265},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.24008160829544067}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20203110s1670b","doi":"https://doi.org/10.1681/asn.20203110s1670b","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1681/asn.20203110s1670b","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3130096759","https://openalex.org/W4415463899","https://openalex.org/W4415453466","https://openalex.org/W2886215886","https://openalex.org/W4403150553","https://openalex.org/W4396994117","https://openalex.org/W3021759361","https://openalex.org/W4403153475","https://openalex.org/W2788982994","https://openalex.org/W4408998888"],"abstract_inverted_index":{"Introduction:":[0],"Pembrolizumab":[1,41,81,314,323],"is":[2,21,248,308],"a":[3,29,37,65,99,242,294,319],"novel":[4,320],"immune":[5,213,348],"checkpoint":[6],"inhibitor":[7,18],"(ICI)":[8],"that":[9,25,304,344],"targets":[10],"programmed":[11],"cell":[12],"death":[13],"protein":[14],"(PD-1)":[15],"signaling.":[16],"Checkpoint":[17],"associated":[19,249,315,352],"nephrotoxicity":[20],"an":[22],"immune-mediated":[23],"process":[24],"can":[26],"manifest":[27],"with":[28,57,64,80,84,250,330,353],"variety":[30],"of":[31,40,67,78,149,172,181,212,236,241,297,313,322,335,341],"clinical":[32],"presentations.":[33],"Here,":[34],"we":[35],"report":[36,318],"unique":[38],"case":[39,321],"induced":[42],"distal":[43,218,243,326],"renal":[44],"tubular":[45],"acidosis":[46,103,286],"(RTA)":[47],"and":[48,88,98,117,135,156,166,203,217,227,275,284],"secondary":[49,331],"adrenal":[50,186],"insufficiency":[51],"(AI)":[52],"which":[53],"was":[54,82,93,123,130,138,144,175,220,238,260,268,290],"successfully":[55],"treated":[56],"steroids.":[58,298],"Case":[59],"Description:":[60],"A":[61,209,222],"72-year-old":[62],"male":[63],"history":[66],"stage":[68],"IIIC":[69],"malignant":[70],"melanoma,":[71],"who":[72],"had":[73,287],"recently":[74],"completed":[75],"3":[76],"cycles":[77],"therapy":[79],"admitted":[83],"generalized":[85],"fatigue,":[86],"weakness,":[87],"anorexia.":[89],"Initial":[90],"work":[91,142],"up":[92,143],"notable":[94,145],"for":[95,146,177],"severe":[96],"hyponatremia,":[97],"non-anion":[100],"gap":[101,122,129,226,231],"metabolic":[102,285],"(NAGMA);":[104],"(Na:":[105],"120":[106],"mmol/L,":[107,110,113],"Cl:":[108],"89":[109],"K:":[111],"3.8":[112],"HCO3:":[114],"20":[115],"mmol/L":[116],"creatinine":[118],"0.67mg/dL).":[119],"Urine":[120],"anion":[121,225],"positive":[124,223,229],"at":[125,132],"8meq/L,":[126],"urine":[127,136,224],"osmolar":[128,230],"low":[131,228],"57":[133],"mosm/kg":[134],"pH":[137],"6.0.":[139],"Subsequent":[140],"laboratory":[141],"AM":[147],"cortisol":[148],"1.0":[150],"ug/dL,":[151],"serum":[152,194,273],"ACTH":[153],"1.4":[154],"pg/mL":[155],"DHEA":[157],"12":[158],"ng/dl.":[159],"Other":[160],"pituitary":[161],"hormones":[162],"including":[163,193],"LH,":[164],"TSH":[165],"FSH":[167],"were":[168,206],"normal.":[169],"An":[170],"MRI":[171],"the":[173,182,234,281,309],"sella":[174],"negative":[176],"hypophysitis.":[178],"CT":[179],"scan":[180],"abdomen":[183],"showed":[184],"no":[185],"hemorrhage":[187],"or":[188],"necrosis.":[189],"Extensive":[190],"serologic":[191],"work-up":[192],"ANA,":[195],"ANCA,":[196],"anti-SSA/SSB,":[197],"Hepatitis":[198,200],"B,":[199],"C,":[201],"C3":[202],"C4":[204],"levels":[205],"all":[207],"unrevealing.":[208],"presumptive":[210],"diagnosis":[211],"mediated":[214,349],"central":[215],"AI":[216,253],"RTA":[219,327],"made.":[221],"(<150mosm/kg)":[232],"in":[233,272],"setting":[235],"NAGMA":[237],"highly":[239],"suggestive":[240],"RTA.":[244],"Although":[245],"this":[246,257],"condition":[247],"hypokalemia,":[251],"simultaneous":[252],"could":[254],"have":[255,302],"offset":[256],"finding.":[258],"He":[259,289],"started":[261],"on":[262,293],"hydrocortisone":[263],"40":[264],"mg":[265],"daily.":[266],"This":[267],"accompanied":[269],"by":[270],"improvement":[271],"sodium":[274],"bicarbonate":[276],"levels.":[277],"Two":[278],"days":[279],"later,":[280],"patient's":[282],"hyponatremia":[283],"resolved.":[288],"eventually":[291],"discharged":[292],"tapering":[295],"dose":[296],"Discussion:":[299],"Recent":[300],"studies":[301],"shown":[303],"acute":[305],"interstitial":[306],"nephritis":[307],"most":[310],"common":[311],"type":[312],"nephrotoxicity.":[316],"We":[317],"toxicity,":[324],"where":[325],"concurrently":[328],"manifests":[329],"AI.":[332],"Rapid":[333],"resolution":[334],"both":[336,347],"these":[337],"conditions":[338],"upon":[339],"initiation":[340],"steroids":[342],"suggests":[343],"they":[345],"are":[346],"adverse":[350],"effects":[351],"Pembrolizumab.":[354]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2024-05-18T00:00:00"}